Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | SHAZ | XRAY |
|---|---|---|
| Price | $47.70 | $8.56 |
| Change today | ▼ 6.12% | ▼ 1.27% |
| Market cap | $1.71B | $1.71B |
| Return, 3 months | – | – |
| Return, year to date | – | – |
| Return, 1 year | – | – |
| P/E (TTM) | -19.4 | -3.1 |
| P/B | 1.5 | 1.3 |
| P/E percentile vs own 5y | 88th | – |
| Dividend yield | – | 3.74% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +130.6% | +50.5% |
| Analyst buy share | 100% | 9% |
| RSI (14) | – | – |
| 30-day volatility | – | – |
| Max drawdown, 1 year | – | – |
| Trend read | – | – |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
